drugset / Trial / NCT06967012

A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures

NCT06967012

Phase 4 Recruiting 30 enrolled Affiliated Hospital of Nantong University
NaSingle-groupOpen-labelTreatment

Summary

This study primarily aims to assess the efficacy and safety of zonisamide when used as an adjunctive therapy for focal epilepsy. The main questions it aims to answer are: 1. Does the frequency of epileptic seizures decrease after oral zonisamide, and does it improve cognitive function? 2. Are there any treatment-emergent adverse events associated with oral administration of zonisamide?

Timeline

Start
2024-08-01
Primary completion
2027-07-31
Completion
2027-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified 4 mg/kg Oral
Subject Zonisamide Other / unclassified 6 mg/kg Oral